Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Interaction between cardiac myosin-binding protein C and formin Fhod3.

Matsuyama S, Kage Y, Fujimoto N, Ushijima T, Tsuruda T, Kitamura K, Shiose A, Asada Y, Sumimoto H, Takeya R.

Proc Natl Acad Sci U S A. 2018 May 8;115(19):E4386-E4395. doi: 10.1073/pnas.1716498115. Epub 2018 Apr 23.

PMID:
29686099
2.

Adrenomedullin: Continuing to explore cardioprotection.

Tsuruda T, Kato J, Kuwasako K, Kitamura K.

Peptides. 2018 Mar 22. pii: S0196-9781(18)30061-5. doi: 10.1016/j.peptides.2018.03.012. [Epub ahead of print]

PMID:
29577955
3.

A high-fat diet is deleterious to mice under glycolysis restriction.

Hao Y, Tsuruda T, Sekita-Hatakeyama Y, Sakamoto S, Kitamura K.

Appl Physiol Nutr Metab. 2018 Apr;43(4):419-422. doi: 10.1139/apnm-2017-0506. Epub 2017 Dec 5.

PMID:
29206484
4.

Transient Left Ventricular Contractile Dysfunction during the Treatment of Rhabdomyolysis: A Case Report and Literature Review.

Tsuruda T, Shinohara N, Ogata M, Kitamura K, Ochiai H.

Intern Med. 2017 Oct 15;56(20):2797-2803. doi: 10.2169/internalmedicine.8478-16. Epub 2017 Sep 15.

5.

18F-Fluorodeoxyglucose Positron Emission Tomography 10 Days Before Onset of Aortic Dissection.

Tsuruda T, Nagamachi S, Yamaguchi M, Sakamoto S, Ishikawa T, Kitamura K.

Circ J. 2018 Mar 23;82(4):1213-1214. doi: 10.1253/circj.CJ-17-0602. Epub 2017 Aug 22. No abstract available.

6.

Diamond-like carbon coating under oleic acid lubrication: Evidence for graphene oxide formation in superlow friction.

De Barros Bouchet MI, Martin JM, Avila J, Kano M, Yoshida K, Tsuruda T, Bai S, Higuchi Y, Ozawa N, Kubo M, Asensio MC.

Sci Rep. 2017 Apr 12;7:46394. doi: 10.1038/srep46394.

7.

Getting Osteoporotic Fracture Risk Into Vascular Structure and Function - Do You Know Your FRAX® Score?

Tsuruda T, Kitamura K.

Circ J. 2017 May 25;81(6):786-787. doi: 10.1253/circj.CJ-17-0221. Epub 2017 Mar 23. No abstract available.

8.

Coexisting Hyponatremia and Decline in Diastolic Blood Pressure Predispose to Atrial Standstill in Hyperkalemic Patients.

Ideguchi T, Tsuruda T, Sato Y, Kitamura K.

Circ J. 2016 Jul 25;80(8):1781-6. doi: 10.1253/circj.CJ-16-0283. Epub 2016 Jun 13.

9.

Multiple 18F-Fluorodeoxyglucose Positron Emission Tomography Scans Showing Progression of Abdominal Aortic Aneurysm: A Case Report.

Tsuruda T, Nagamachi S, Nishimura M, Nakamura K, Kitamura K.

Medicine (Baltimore). 2016 May;95(19):e3650. doi: 10.1097/MD.0000000000003650.

10.

Antibody-mediated neutralization of autocrine Gas6 inhibits the growth of pancreatic ductal adenocarcinoma tumors in vivo.

Moody G, Belmontes B, Masterman S, Wang W, King C, Murawsky C, Tsuruda T, Liu S, Radinsky R, Beltran PJ.

Int J Cancer. 2016 Sep 15;139(6):1340-9. doi: 10.1002/ijc.30180. Epub 2016 May 31.

11.

Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice.

Tsuruda T, Sekita-Hatakeyama Y, Hao Y, Sakamoto S, Kurogi S, Nakamura M, Udagawa N, Funamoto T, Sekimoto T, Hatakeyama K, Chosa E, Kato J, Asada Y, Kitamura K.

Hypertension. 2016 May;67(5):848-56. doi: 10.1161/HYPERTENSIONAHA.115.06689. Epub 2016 Mar 21.

PMID:
27001297
12.

Identification of Human Islet Amyloid Polypeptide as a BACE2 Substrate.

Rulifson IC, Cao P, Miao L, Kopecky D, Huang L, White RD, Samayoa K, Gardner J, Wu X, Chen K, Tsuruda T, Homann O, Baribault H, Yamane H, Carlson T, Wiltzius J, Li Y.

PLoS One. 2016 Feb 3;11(2):e0147254. doi: 10.1371/journal.pone.0147254. eCollection 2016.

13.

Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene.

Hao Y, Tsuruda T, Sekita-Hatakeyama Y, Kurogi S, Kubo K, Sakamoto S, Nakamura M, Udagawa N, Sekimoto T, Hatakeyama K, Chosa E, Asada Y, Kitamura K.

Cardiovasc Res. 2016 May 1;110(1):62-72. doi: 10.1093/cvr/cvw025. Epub 2016 Jan 29.

PMID:
26825553
14.

Osteoprotegerin: osteo-vascular connection.

Tsuruda T.

J Atheroscler Thromb. 2015;22(3):233-4. doi: 10.5551/jat.ED004. Epub 2015 Feb 6. No abstract available.

15.

Stereoselective synthesis of the C1-C29 part of amphidinol 3.

Tsuruda T, Ebine M, Umeda A, Oishi T.

J Org Chem. 2015 Jan 16;80(2):859-71. doi: 10.1021/jo502322m. Epub 2015 Jan 7.

PMID:
25517178
16.

Impact of age-dependent adventitia inflammation on structural alteration of abdominal aorta in hyperlipidemic mice.

Sakamoto S, Tsuruda T, Hatakeyama K, Imamura T, Asada Y, Kitamura K.

PLoS One. 2014 Aug 25;9(8):e105739. doi: 10.1371/journal.pone.0105739. eCollection 2014.

17.

Osteoprotegerin is secreted into the coronary circulation: a possible association with the renin-angiotensin system and cardiac hypertrophy.

Koyama S, Tsuruda T, Ideguchi T, Kawagoe J, Onitsuka H, Ishikawa T, Date H, Hatakeyama K, Asada Y, Kato J, Kitamura K.

Horm Metab Res. 2014 Jul;46(8):581-6. doi: 10.1055/s-0034-1375611. Epub 2014 May 8.

PMID:
24810471
18.

Reduced fractional shortening of right ventricular outflow tract is associated with adverse outcomes in patients with left ventricular dysfunction.

Yamaguchi M, Tsuruda T, Watanabe Y, Onitsuka H, Furukawa K, Ideguchi T, Kawagoe J, Ishikawa T, Kato J, Takenaga M, Kitamura K.

Cardiovasc Ultrasound. 2013 Jun 3;11:19. doi: 10.1186/1476-7120-11-19.

19.

Effect of pH, temperature, and salt on the stability of Escherichia coli- and Chinese hamster ovary cell-derived IgG1 Fc.

Li CH, Narhi LO, Wen J, Dimitrova M, Wen ZQ, Li J, Pollastrini J, Nguyen X, Tsuruda T, Jiang Y.

Biochemistry. 2012 Dec 18;51(50):10056-65. doi: 10.1021/bi300702e. Epub 2012 Dec 4.

PMID:
23078371
20.

Postinfarction dissecting intramyocardial haematoma in a patient treated with immunosuppressant.

Sakata K, Tsuruda T, Imamura T, Kitamura K.

BMJ Case Rep. 2012 Oct 6;2012. pii: bcr2012006904. doi: 10.1136/bcr-2012-006904. No abstract available.

21.

Different distribution of pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques.

Matsuura Y, Hatakeyama K, Imamura T, Tsuruda T, Shibata Y, Kodama T, Kitamura K, Asada Y.

J Atheroscler Thromb. 2012;19(9):837-45. Epub 2012 Jul 11.

22.

Inhibition of development of abdominal aortic aneurysm by glycolysis restriction.

Tsuruda T, Hatakeyama K, Nagamachi S, Sekita Y, Sakamoto S, Endo GJ, Nishimura M, Matsuyama M, Yoshimura K, Sato Y, Onitsuka T, Imamura T, Asada Y, Kitamura K.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1410-7. doi: 10.1161/ATVBAHA.111.237065. Epub 2012 Apr 12.

PMID:
22499992
23.

Adrenomedullin production is increased in colorectal adenocarcinomas; its relation to matrix metalloproteinase-9.

Hikosaka T, Tsuruda T, Nagata S, Kuwasako K, Tsuchiya K, Hoshiko S, Inatsu H, Chijiiwa K, Kitamura K.

Peptides. 2011 Sep;32(9):1825-31. doi: 10.1016/j.peptides.2011.07.012. Epub 2011 Aug 3.

PMID:
21839130
24.

[Macrophage: pathogenesis in the progression of atherosclerosis].

Tsuruda T, Hatakeyama K, Kitamura K.

Nihon Rinsho. 2011 Jan;69(1):45-9. Review. Japanese.

PMID:
21226259
25.

Herbal dietary supplement: continuing to explore cardiovascular protection.

Tsuruda T.

Cardiovasc Res. 2010 Dec 1;88(3):387-8. doi: 10.1093/cvr/cvq320. Epub 2010 Oct 8. No abstract available.

PMID:
20935167
26.

Stromal cell biology--a way to understand the evolution of cardiovascular diseases.

Tsuruda T, Imamura T, Hatakeyama K, Asada Y, Kitamura K.

Circ J. 2010 Jun;74(6):1042-50. Epub 2010 Apr 6. Review.

27.

Biochemical characterization of AMG 102: a neutralizing, fully human monoclonal antibody to human and nonhuman primate hepatocyte growth factor.

Burgess TL, Sun J, Meyer S, Tsuruda TS, Sun J, Elliott G, Chen Q, Haniu M, Barron WF, Juan T, Zhang K, Coxon A, Kendall RL.

Mol Cancer Ther. 2010 Feb;9(2):400-9. doi: 10.1158/1535-7163.MCT-09-0824. Epub 2010 Feb 2.

28.

Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1alpha in rat heart.

Tsuruda T, Hatakeyama K, Masuyama H, Sekita Y, Imamura T, Asada Y, Kitamura K.

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1274-80. doi: 10.1152/ajpheart.00503.2009. Epub 2009 Aug 14.

29.

Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart.

Masuyama H, Tsuruda T, Sekita Y, Hatakeyama K, Imamura T, Kato J, Asada Y, Stasch JP, Kitamura K.

Hypertens Res. 2009 Jul;32(7):597-603. doi: 10.1038/hr.2009.64. Epub 2009 May 8.

PMID:
19424280
30.

Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm.

Tsuruda T, Kato J, Hatakeyama K, Kojima K, Yano M, Yano Y, Nakamura K, Nakamura-Uchiyama F, Matsushima Y, Imamura T, Onitsuka T, Asada Y, Nawa Y, Eto T, Kitamura K.

Circ Res. 2008 Jun 6;102(11):1368-77. doi: 10.1161/CIRCRESAHA.108.173682. Epub 2008 May 1.

PMID:
18451339
31.

High-throughput assays for sirtuin enzymes: a microfluidic mobility shift assay and a bioluminescence assay.

Liu Y, Gerber R, Wu J, Tsuruda T, McCarter JD.

Anal Biochem. 2008 Jul 1;378(1):53-9. doi: 10.1016/j.ab.2008.02.018. Epub 2008 Mar 4.

PMID:
18358225
32.

Medial and adventitial macrophages are associated with expansive atherosclerotic remodeling in rabbit femoral artery.

Yamashita A, Shoji K, Tsuruda T, Furukoji E, Takahashi M, Nishihira K, Tamura S, Asada Y.

Histol Histopathol. 2008 Feb;23(2):127-36. doi: 10.14670/HH-23.127.

PMID:
17999368
33.

Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus.

Tsuruda T, Kato J, Sumi T, Mishima K, Masuyama H, Nakao H, Imamura T, Eto T, Kitamura K.

Vasc Health Risk Manag. 2007;3(4):417-23.

34.

The selectivity of tyrosine 280 of human 11beta-hydroxysteroid dehydrogenase type 1 in inhibitor binding.

Kim KW, Wang Z, Busby J, Tsuruda T, Chen M, Hale C, Castro VM, Svensson S, Nybo R, Xiong F, Wang M.

FEBS Lett. 2007 Mar 6;581(5):995-9. Epub 2007 Feb 8.

35.

Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats.

Masuyama H, Tsuruda T, Kato J, Imamura T, Asada Y, Stasch JP, Kitamura K, Eto T.

Hypertension. 2006 Nov;48(5):972-8. Epub 2006 Sep 18.

PMID:
16982964
36.

The role of tyrosine 177 in human 11beta-hydroxysteroid dehydrogenase type 1 in substrate and inhibitor binding: an unlikely hydrogen bond donor for the substrate.

Kim KW, Wang Z, Busby J, Tsuruda T, Chen M, Hale C, Castro VM, Svensson S, Nybo R, Xiong F, Wang M.

Biochim Biophys Acta. 2006 Apr;1764(4):824-30. Epub 2006 Mar 20.

PMID:
16580270
37.

Adrenomedullin in mast cells of abdominal aortic aneurysm.

Tsuruda T, Kato J, Hatakeyama K, Yamashita A, Nakamura K, Imamura T, Kitamura K, Onitsuka T, Asada Y, Eto T.

Cardiovasc Res. 2006 Apr 1;70(1):158-64. Epub 2006 Mar 9.

PMID:
16524566
38.

Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.

Sadzuka Y, Sugiyama I, Tsuruda T, Sonobe T.

Int J Pharm. 2006 Apr 7;312(1-2):83-9. Epub 2006 Feb 2.

PMID:
16457972
39.

Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.

Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R.

Cancer Res. 2006 Feb 1;66(3):1721-9. Erratum in: Cancer Res. 2006 Jun 1;66(11):5976.

40.

Adrenomedullin: a protective factor for blood vessels.

Kato J, Tsuruda T, Kita T, Kitamura K, Eto T.

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2480-7. Epub 2005 Sep 1. Review.

PMID:
16141406
41.

Beyond vasodilation: the antioxidant effect of adrenomedullin in Dahl salt-sensitive rat aorta.

Cao YN, Kuwasako K, Kato J, Yanagita T, Tsuruda T, Kawano J, Nagoshi Y, Chen AF, Wada A, Suganuma T, Eto T, Kitamura K.

Biochem Biophys Res Commun. 2005 Jul 8;332(3):866-72.

PMID:
15913562
42.

Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats.

Tsuruda T, Kato J, Hatakeyama K, Masuyama H, Cao YN, Imamura T, Kitamura K, Asada Y, Eto T.

Cardiovasc Res. 2005 Mar 1;65(4):921-9.

PMID:
15721873
43.

Adrenomedullin alleviates not only neointimal formation but also perivascular hyperplasia following arterial injury in rats.

Tsuruda T, Kato J, Matsui E, Hatakeyama K, Masuyama H, Imamura T, Kitamura K, Asada Y, Eto T.

Eur J Pharmacol. 2005 Jan 31;508(1-3):201-4. Epub 2005 Jan 7.

PMID:
15680272
44.

[Characterization and cytotoxicity of mixed PEG-DSG modified liposomes].

Sadzuka Y, Tsuruda T, Sonobe T.

Yakugaku Zasshi. 2005 Jan;125(1):149-57. Japanese.

45.

Adrenomedullin induces matrix metalloproteinase-2 activity in rat aortic adventitial fibroblasts.

Tsuruda T, Kato J, Cao YN, Hatakeyama K, Masuyama H, Imamura T, Kitamura K, Asada Y, Eto T.

Biochem Biophys Res Commun. 2004 Dec 3;325(1):80-4.

PMID:
15522203
46.

[Effect of adrenomedullin on cardiac myocytes and fibroblasts].

Tsuruda T, Kato J, Eto T.

Nihon Rinsho. 2004 Sep;62 Suppl 9:233-6. Review. Japanese. No abstract available.

PMID:
15506376
47.

Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.

Cataliotti A, Boerrigter G, Costello-Boerrigter LC, Schirger JA, Tsuruda T, Heublein DM, Chen HH, Malatino LS, Burnett JC Jr.

Circulation. 2004 Apr 6;109(13):1680-5. Epub 2004 Mar 15.

PMID:
15023890
48.

Matrix metalloproteinases: pathways of induction by bioactive molecules.

Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr.

Heart Fail Rev. 2004 Jan;9(1):53-61. Review.

PMID:
14739768
49.

Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins.

Kuwasako K, Cao YN, Nagoshi Y, Tsuruda T, Kitamura K, Eto T.

Mol Pharmacol. 2004 Jan;65(1):207-13.

50.

Cardiac amyloidosis associated with a novel transthyretin aspartic acid-18 glutamic acid de novo mutation.

Imamura T, Nakazato M, Date Y, Komatsu H, Ashizuka S, Aoyama F, Sumi M, Tsuruda T, Ishikawa T, Hirayama N, Matsuo T, Eto T.

Circ J. 2003 Nov;67(11):965-8.

Supplemental Content

Loading ...
Support Center